The companies are already planning a second set of experiments with the goal of progressing to flight tests
The American research agency anticipates a 30% CAGR for the vehicle market between 2022-2032
Revenue mushrooming was attributed to the company's cannabis operations and functional fungi drinks
Decentralized financial market infrastructure eliminates counterparty risk
The initial project will be a 1.25MW hydrogen plant in Sicily producing 46 tonnes per year
The company narrowed its net losses by approximately $3.5 million since last year
PharmAla will have exclusive rights to resell Mindset's cGMP psilocybin to designated researchers
'Powering Past Coal' report is the result of 5 years of work from the Powering Past Coal Alliance comprised of governments worldwide
The non-profit trade association received a high level of interest from multiple branches of government
The new survey showed that 65% of respondents will choose pot over alcohol consumption during the holidays
SNDL has added a substantial EU-GMP-certified cultivation facility to its resources with the transaction
Companies say addition of BLK MKT to IM's product portfolio will strengthen their relationship
The company credits its recent financial success to the acquisitions of Alpha Growers and Magic 1 Promotions
The company says the FDA is very interested in developing IHL-216A for the treatment of TBI
The new products are said to work in unison with the endocannabinoid system
The company attributes its recent financial success to CBD and oil-absorbing product distribution
Nabis is one of the largest cannabis distributors in California
Cybin will pay Mindset an initial US$500K and 'development milestone payments' that could potentially total US$9.5M afterward
Company and Pure Sunfarms subsidiary get recognized for multiple accomplishments
Kaya Cast is a podcast intended to help equip dispensaries with valuable tools and resources
Acquisition will expand Freedom's production capacity and lower its production costs
Legalization of cannabis in multiple countries such as the U.S., Canada and Australia will be primary driver of market growth
Company claims it will 'disrupt cannabis industry' with its new proprietary technology
Clinical trial will be conducted as part of the ATMA Journey Centre's psychedelic-assisted therapist training program
Application follows successful pre-clinical animal studies at the University of Arkansas
Growing scope of medicinal applications for CBD is a key driver of the anticipated market growth
Flagship product from company's medical cannabis division now set for clinical trial use
Prominent speaker lineup promised for 'the largest cannabis investing and finance event' this September
Company still expects to observe revenue growth for the remainder of 2022
Company revenue increased 49% year over year and 1% sequentially, but annual operational costs increased by 111%
She explained that as Bhang grows, her vision has not been consistent with that of its largest shareholders
Renowned distributor set to help Tilray's Hemp Foods division supply CBD drinks to 13 states
New inhalable drug containing CBD designed for efficacious treatment of brain injuries
New French-Canadian inspired subsidiary will soon make its way to remaining provinces
Clinical psychedelic sector value anticipated to ascend significantly into 2028
New blockchain-powered cannabis industry platform aims to be community hub for industry
Flexible new curriculum designed to help students into cannabis career paths
Preliminary event for November canna-conference to be held this August
Company duo claims to provide pot shop owners with operational and business insights
'Just Hits Different' campaign prompts over 1,400 retailers to host pop-up flavour sampling events








































